Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Aug 01, 2019 11:53am
79 Views
Post# 29984362

RE:RE:RE:RE:What a PLAN!

RE:RE:RE:RE:What a PLAN!
Ric0419 wrote:
That's where you are wrong progressive!!  Aphria's products are way better than black market!  I've been an Aphria medical patient for 5 years and have tried other LP's. Yes, Aphria didn't have the greatest products to begin with but were the cheapest.  They have since change their growing methods and it shows!  Just got a batch of 28% Mohawk and it's unreal!  Also just finished some 23% Alien Dawg which was also phenominal blew away anything my friends try to concinve me is "chronic" from the black market.  

Aphria has also produced 99% distilate which you will hear about once their extraction facility gets approved.  

Everyone is so worried about share price while Aphria is worried about getting their product right and making it the best and it's showing!
It's all about revenue and profitability.  The ER will be a good improvement from last IMHO.  The products are showing good reviews and they are selling out on OSC.  This is a good sign.  The replenishment rate on OSC is good.  As quickly as they are sold out they are being replenished.  Stats can is showing month over month rec sales increases.  There is no reason to not expect a good revenue number for this ER.  

Irwin clearly said " If I had the product I could sell $400-$500M more a year."  That is a strong statement. He clearly has confidence in selling the product. The DD license is the key factor holding him back.

I am looking for a pleasant surprise this ER. I would like to see the issues of low margin behind us with the packaging changes.  

As for further writedowns .  I don't see it happening this Q.  

Bullboard Posts